Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up imaging study in glaucoma and ocular hypertension
NL-OMON20750Active, not recruiting
- Sponsor
- Het Oogziekenhuis Rotterdam
- Start
- Jan 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of timolol and betaxolol in Glaucoma and ocular hypertension (4 arms), sponsored by Het Oogziekenhuis Rotterdam. Primary endpoints: Sensitivity of glaucoma diagnostics, Specificity of glaucoma diagnostics and 1 more. Started Jan 2000; status: active, not recruiting.
02
Drugs
timololbetaxolol
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NL-OMON20750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20750.